831
|
|
|
Rho GTPase activating protein 44 |
NPC-A-10, RICH2 |
|
832
|
|
|
Rho GTPase activating protein 45 |
HA-1, HLA-HA1, HMHA1 |
|
833
|
|
|
Rho GTPase activating protein 5 |
GFI2, RhoGAP5, p190-B, p190BRhoGAP |
|
834
|
|
|
Rho GTPase activating protein 6 |
RHOGAP6, RHOGAPX-1 |
|
835
|
|
|
Rho GTPase activating protein 8 |
BPGAP1, PP610 |
|
836
|
|
|
Rho GTPase activating protein 9 |
10C, RGL1 |
|
837
|
|
|
Rho GDP dissociation inhibitor alpha |
GDIA1, HEL-S-47e, NPHS8, RHOGDI, RHOGDI-1 |
|
838
|
|
|
Rho GDP dissociation inhibitor beta |
D4, GDIA2, GDID4, LYGDI, Ly-GDI, RAP1GN1, RhoGDI2 |
|
839
|
|
|
Rho guanine nucleotide exchange factor 1 |
GEF1, IMD62, LBCL2, LSC, P115-RHOGEF, SUB1.5 |
|
840
|
|
|
Rho guanine nucleotide exchange factor 10 |
GEF10, SNCV |
Bipolar disorder, Charcot-marie-tooth disease, Kidney disease, Colorectal cancer, Dementia, Major depressive disorder, Genetic peripheral neuropathy, Multiple sclerosis, Myopathy, Obesity, Peripheral neuropathy, Salivary gland disease, Schizophrenia, Spinal muscular atrophy, Vesicoureteral reflux |